The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.

Abstract

Peritoneal carcinomatosis is a common and often fatal late-stage complication of many gastrointestinal and gynecologic malignancies. This review discusses the ongoing evolution of diagnostic and treatment strategies for peritoneal carcinomatosis and the role that molecular imaging and radioimmunotherapy may play in improving patient survival. An overview of recent developments in targeted imaging and therapeutics for peritoneal carcinomatosis, as well as the authors' opinions as to future developments in this field is also provided.

Statistics

02040200920102011201220132014201520162017
Citations per Year

51 Citations

Semantic Scholar estimates that this publication has 51 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Gunn2007TheER, title={The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.}, author={Andrew J. Gunn and Martin W. Brechbiel and Peter L. Choyke}, journal={Expert opinion on drug delivery}, year={2007}, volume={4 4}, pages={389-402} }